Core Viewpoint - Exponent, Inc. is set to report its financial results for the second quarter of fiscal year 2025 on July 31, 2025, with a conference call scheduled to discuss the results and business performance [1]. Group 1: Financial Results Announcement - Exponent, Inc. will announce its second quarter financial results for the period ending July 4, 2025, after market close on July 31, 2025 [1]. - The conference call will be hosted by Dr. Catherine Corrigan, CEO, and Richard Schlenker, CFO, at 4:30 p.m. ET [1][2]. Group 2: Conference Call Details - The conference call can be accessed via live call numbers (844) 481-2781 or (412) 317-0672 [2]. - An archived webcast of the conference call will be available on the Investor Relations section of Exponent's website [2]. - A telephonic replay of the conference call will be available until August 7, 2025, with specific dialing instructions provided [2]. Group 3: Company Overview - Exponent integrates over 90 technical disciplines and employs more than 950 consultants to assist clients across various industries [3]. - The company focuses on failure analysis and developing solutions aimed at creating a safer, healthier, and more sustainable world [3][4]. - Exponent's global resources, including consultants, laboratories, and databases, work collaboratively to provide insights for multinational companies, startups, law firms, insurance companies, and governments [4].

[PART I – FINANCIAL INFORMATION](index=3&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) [Financial Statements (unaudited)](index=3&type=section&id=Item%201.%20Financial%20Statements) The unaudited condensed consolidated financial statements for Q1 2025 present flat revenues, a decline in net income and operating cash flow, and balance sheet changes, with accompanying notes providing essential financial context [Condensed Consolidated Balance Sheets](index=3&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of April 4, 2025, the balance sheet shows a decrease in total assets and liabilities, primarily due to reduced cash and accrued payroll, while total stockholders' equity increased Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | April 4, 2025 | January 3, 2025 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $245,113 | $258,901 | | Total current assets | $432,796 | $446,881 | | Total assets | $763,239 | $777,270 | | **Liabilities & Equity** | | | | Total current liabilities | $130,272 | $163,183 | | Total liabilities | $321,831 | $356,202 | | Total stockholders' equity | $441,408 | $421,068 | [Condensed Consolidated Statements of Income](index=4&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) For Q1 2025, revenues remained flat, but net income and diluted earnings per share decreased significantly, largely due to a negative swing in miscellaneous income, while the quarterly dividend per share increased Q1 2025 vs. Q1 2024 Income Statement (in thousands, except per share data) | Metric | Q1 2025 (ended Apr 4) | Q1 2024 (ended Mar 29) | Change | | :--- | :--- | :--- | :--- | | Revenues | $145,507 | $144,933 | +0.4% | | Operating Income | $44,432 | $30,713 | +44.7% | | Net Income | $26,650 | $30,142 | -11.6% | | Diluted EPS | $0.52 | $0.59 | -11.9% | | Dividends per share | $0.30 | $0.28 | +7.1% | - The significant increase in **operating income year-over-year** is primarily due to a **$15,600 thousand decrease** in compensation expense related to the change in value of deferred compensation plan assets, which is offset in 'Other income (loss), net'[9](index=9&type=chunk)[79](index=79&type=chunk) [Condensed Consolidated Statements of Comprehensive Income](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Comprehensive%20Income) Comprehensive income for Q1 2025 decreased to **$27,596 thousand** from **$29,932 thousand** in Q1 2024, reflecting lower net income partially offset by a positive foreign currency translation adjustment Comprehensive Income (in thousands) | Component | Q1 2025 (ended Apr 4) | Q1 2024 (ended Mar 29) | | :--- | :--- | :--- | | Net income | $26,650 | $30,142 | | Foreign currency translation adjustments | $946 | $(210) | | **Comprehensive income** | **$27,596** | **$29,932** | [Condensed Consolidated Statements of Stockholders' Equity](index=6&type=section&id=Condensed%20Consolidated%20Statements%20of%20Stockholders%27%20Equity) Total stockholders' equity increased by **$20,340 thousand** during Q1 2025, driven by net income, partially offset by dividends and treasury stock purchases - Key changes in stockholders' equity for Q1 2025 include: **net income of $26,650 thousand**, **dividends of $15,800 thousand**, and **treasury stock purchases of $5,025 thousand**[15](index=15&type=chunk) [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash from operating activities decreased in Q1 2025 due to working capital changes, while cash used in financing activities fell due to lower stock repurchases, with cash and cash equivalents ending at **$245,113 thousand** Cash Flow Summary (in thousands) | Cash Flow Activity | Q1 2025 (ended Apr 4) | Q1 2024 (ended Mar 29) | | :--- | :--- | :--- | | Net cash provided by operating activities | $7,274 | $10,432 | | Net cash used in investing activities | $(1,754) | $(1,482) | | Net cash used in financing activities | $(20,049) | $(27,227) | | **Net decrease in cash** | **$(13,788)** | **$(18,485)** | [Notes to Unaudited Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Unaudited%20Condensed%20Consolidated%20Financial%20Statements) The notes provide critical context to the financial statements, detailing revenue sources, segment performance, stock compensation, and a significant long-term lease extension, along with a subsequent dividend declaration - In Q1 2025, **82%** of the company's revenue was generated from time and materials contracts, compared to **80%** in Q1 2024[28](index=28&type=chunk) Segment Revenues (in thousands) | Segment | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Engineering and Other Scientific | $122,135 | $121,471 | | Environmental and Health | $23,372 | $23,462 | | **Total revenues** | **$145,507** | **$144,933** | - The company extended its land lease in Arizona to January 2043, resulting in additional non-cash rent expense of approximately **$1,085 thousand** during Q1 2025[63](index=63&type=chunk)[80](index=80&type=chunk) - On May 1, 2025, the Board of Directors declared a cash dividend of **$0.30 per share**[66](index=66&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=21&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management reported a slight increase in quarterly revenues to **$145,507 thousand**, offset by a **12%** decrease in net income to **$26,650 thousand**, attributed to higher operating expenses and a reduced tax benefit, while affirming focus on talent, expense control, and capital returns [Executive Summary](index=21&type=section&id=Executive%20Summary) Revenues for Q1 2025 increased slightly to **$145,507 thousand**, while net income decreased **12%** to **$26,650 thousand**, primarily due to higher operating expenses and a lower tax benefit, with growth in certain sectors offset by easing demand in consumer electronics - Revenues increased slightly to **$145,507 thousand** in Q1 2025, while net income decreased **12%** to **$26,650 thousand**[72](index=72&type=chunk)[73](index=73&type=chunk) - Growth drivers included dispute-related activities in chemicals, transportation, and utilities, while the consumer electronics sector saw an expected easing[72](index=72&type=chunk) [Results of Operations](index=22&type=section&id=Results%20of%20Operations) Total revenues grew **0.4%**, with operating income increasing **44.7%** to **$44,432 thousand**, largely due to a **$15,600 thousand** deferred compensation adjustment, despite rising other operating expenses from a lease extension and IT spending - Billable hours decreased **4%** to **376,000**, while utilization remained flat at **75%** year-over-year[75](index=75&type=chunk) - Compensation expenses decreased **16.0%** primarily due to a **$15,600 thousand** change in the value of assets in the deferred compensation plan, which had an offsetting loss in 'Other income, net'[78](index=78&type=chunk)[79](index=79&type=chunk) - Other operating expenses increased **14.9%**, mainly from a **$1,100 thousand** non-cash rent expense for the Arizona land lease extension and a **$336 thousand** increase in computer-related expenses[80](index=80&type=chunk) [Liquidity and Capital Resources](index=26&type=section&id=Liquidity%20and%20Capital%20Resources) The company ended Q1 2025 with **$245,113 thousand** in cash, with net cash from operations at **$7,274 thousand**, and significant future commitments including an extended Arizona land lease with annual payments increasing to approximately **$6,200 thousand** starting in 2028 Cash Flow Summary (in thousands) | Activity | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $7,274 | $10,432 | | Net cash used in investing activities | $(1,754) | $(1,482) | | Net cash used in financing activities | $(20,049) | $(27,227) | - The company's Arizona land lease was extended, with annual payments increasing from **$1,000 thousand** to approximately **$6,200 thousand** beginning in January 2028[94](index=94&type=chunk) [Non-GAAP Financial Measures](index=27&type=section&id=Non-GAAP%20Financial%20Measures) The company uses non-GAAP measures EBITDA and EBITDAS to evaluate performance, with EBITDA for Q1 2025 at **$37,538 thousand**, representing **27.3%** of revenues before reimbursements, a decrease from the prior year due to higher stock-based compensation and occupancy expense EBITDA Reconciliation and Margin (in thousands) | Metric | Q1 2025 | Q1 2024 | | :--- | :--- | :--- | | Net income | $26,650 | $30,142 | | EBITDA | $37,538 | $40,121 | | EBITDAS | $45,717 | $47,461 | | EBITDA as a % of revenues before reimbursements | 27.3% | 29.2% | [Quantitative and Qualitative Disclosures About Market Risk](index=29&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company faces interest rate risk on cash and foreign currency risk from international operations, which it manages through investment policy and without derivative instruments, having experienced no significant impact from currency fluctuations to date - The company has **interest rate risk** associated with its cash and cash equivalents, managed via an investment policy with short maturities[102](index=102&type=chunk) - Foreign currency risk exists from operations denominated in British Pound, Euro, Chinese Yuan, and Hong Kong Dollar, with the company not using foreign exchange contracts to hedge this exposure[103](index=103&type=chunk)[106](index=106&type=chunk) [Controls and Procedures](index=29&type=section&id=Item%204.%20Controls%20and%20Procedures) As of April 4, 2025, management concluded that the company's disclosure controls and procedures were effective, with no material changes to internal control over financial reporting during the quarter - Management concluded that the company's disclosure controls and procedures were effective as of April 4, 2025[107](index=107&type=chunk) - No changes in internal control over financial reporting occurred during the quarter that have materially affected, or are reasonably likely to materially affect, internal controls[108](index=108&type=chunk) [PART II – OTHER INFORMATION](index=30&type=section&id=PART%20II%20%E2%80%93%20OTHER%20INFORMATION) [Legal Proceedings](index=30&type=section&id=Item%201.%20Legal%20Proceedings) The company is not currently involved in any material legal proceedings - Exponent is not engaged in any material legal proceedings[109](index=109&type=chunk) [Risk Factors](index=30&type=section&id=Item%201A.%20Risk%20Factors) There have been no material changes to the risk factors previously disclosed in the company's 2024 Annual Report on Form 10-K - No material changes from risk factors as previously discussed in the Company's 2024 Annual Report[110](index=110&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=30&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) During Q1 2025, the company repurchased **65,000 shares** of common stock for approximately **$5,025 thousand**, with **$89,300 thousand** remaining available for repurchase under existing programs Common Stock Repurchases in Q1 2025 | Period | Total Shares Purchased | Average Price Paid Per Share | Total Value (in thousands) | | :--- | :--- | :--- | :--- | | March 1 to April 4 | 65,000 | $77.31 | $5,025 | | **Total** | **65,000** | **$77.31** | **$5,025** | - As of April 4, 2025, approximately **$89,300 thousand** remained available for repurchase under the company's stock repurchase programs, which have no expiration dates[111](index=111&type=chunk) [Defaults Upon Senior Securities](index=30&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) Not applicable - Not applicable[112](index=112&type=chunk) [Mine Safety Disclosures](index=30&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) Not applicable - Not applicable[113](index=113&type=chunk) [Other Information](index=30&type=section&id=Item%205.%20Other%20Information) No directors or officers of the company adopted, modified, or terminated a Rule 10b5-1 trading plan or a non-Rule 10b5-1 trading arrangement during the first fiscal quarter of 2025 - None of the Company's directors or officers adopted, modified, or terminated a Rule 10b5-1 trading arrangement during the fiscal quarter[114](index=114&type=chunk) [Exhibits](index=31&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including CEO and CFO certifications and Inline XBRL financial data files - The report includes CEO and CFO certifications pursuant to Rule 13a-14(a) and 18 U.S.C. Section 1350, as well as Inline XBRL documents[115](index=115&type=chunk)

Core Viewpoint - Exponent, Inc. is conducting its first quarter 2025 earnings conference call to discuss financial results and market opportunities [1][3]. Group 1: Company Overview - The conference call features key participants including Dr. Catherine Corrigan, President and CEO, and Rich Schlenker, EVP and CFO [4]. - The call is being recorded and will be available for webcast on the company's investor relations website [3]. Group 2: Financial Results and Forward-Looking Statements - The discussion includes forward-looking statements regarding Exponent's market opportunities and future financial results, which are subject to risks and uncertainties [5]. - Actual results may differ materially from those discussed due to various factors outlined in Exponent's periodic SEC filings [5].

Group 1 - Exponent (EXPO) reported quarterly earnings of $0.52 per share, exceeding the Zacks Consensus Estimate of $0.48 per share, but down from $0.59 per share a year ago, representing an earnings surprise of 8.33% [1] - The company achieved revenues of $137.44 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 2.92%, and showing a slight increase from $137.21 million year-over-year [2] - Exponent has outperformed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] Group 2 - The stock has underperformed the market, losing about 11.7% since the beginning of the year compared to the S&P 500's decline of 5.3% [3] - The current consensus EPS estimate for the upcoming quarter is $0.54 on revenues of $134.15 million, and for the current fiscal year, it is $1.98 on revenues of $531.67 million [7] - The Consulting Services industry, to which Exponent belongs, is currently ranked in the top 11% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Financial Data and Key Metrics Changes - For Q1 2025, total revenues were approximately flat at $145.5 million, with net revenues also flat at $137.4 million compared to Q1 2024 [15][21] - Net income decreased to $26.7 million or $0.52 per diluted share, down from $30.1 million or $0.59 per diluted share in the prior year [15][16] - EBITDA for the quarter decreased by 6% to $37.5 million, producing a margin of 27.3% of net revenues, compared to 29.2% in Q1 2024 [16][20] - Billable hours decreased by 4% year over year to approximately 376,000, and average technical full-time equivalent employees decreased by 4% to 966 [18] Business Line Data and Key Metrics Changes - The Engineering and Scientific segment represented 84% of revenues before reimbursement, with revenues flat in Q1 2025 [21] - The Environmental and Health segment represented 16% of revenues before reimbursement, with a 2% increase driven by engagements in the chemicals industry [21][22] Market Data and Key Metrics Changes - The consumer products industry accounts for approximately 25% of revenue, with two-thirds being proactive work for consumer electronics clients [9] - The energy industry represents about 20% of revenue, split evenly between reactive and proactive services, with growing demand driven by AI and infrastructure development [10] - The transportation industry contributes mid-teens percentage of revenue, with 90% being reactive, driven by disputes in advanced vehicle technologies [11] Company Strategy and Development Direction - The company maintains a diversified business model, with 60% of work being reactive and 40% proactive, allowing it to navigate economic cycles effectively [7][14] - The focus remains on advancing capabilities, investing in talent, and delivering insights to help clients adapt to changes in their industries [31] - The company is strategically hiring in areas with increasing demand, such as automated vehicles and digital health [64] Management's Comments on Operating Environment and Future Outlook - Management noted macroeconomic uncertainty but expressed confidence in the company's resilience and ability to generate long-term profitable growth [14][30] - The company expects revenue before reimbursements to decline in the low single digits for Q2 2025, with EBITDA margins projected at 26% to 27% [22][24] - Management highlighted ongoing opportunities in regulatory consulting and compliance work, particularly in the chemicals industry [29] Other Important Information - The company anticipates a tax rate of approximately 28% for Q2 2025, up from 26% in the same quarter last year [27] - Capital expenditures for the full year 2025 are expected to be between $10 million and $12 million [28] Q&A Session Summary Question: Growth rates in proactive and reactive work - The reactive business saw low single-digit growth, offset by a slight decline in proactive services overall [35][36] Question: Changes in productivity across end markets - Clients are exploring supply chain diversification, which may lead to increased demand, but changes take time to manifest [38][39] Question: Second quarter outlook and utilization - Utilization is expected to be slightly below last year, impacted by the July 4 holiday and some delays in client projects [44][46] Question: FTE growth in a choppy environment - The company plans to continue hiring in areas of increasing demand, expecting a 4% increase in headcount by year-end [64][66]

Financial Data and Key Metrics Changes - For Q1 2025, total revenues were approximately flat at $145.5 million, with net revenues also flat at $137.4 million compared to Q1 2024 [14] - Net income decreased to $26.7 million or $0.52 per diluted share, down from $30.1 million or $0.59 per diluted share in the prior year [15] - EBITDA decreased by 6% to $37.5 million, producing a margin of 27.3% of net revenues, compared to 29.2% in Q1 2024 [16] - Billable hours decreased by 4% year over year to approximately 376,000, and average technical full-time equivalent employees decreased by 4% to 966 [17] Business Line Data and Key Metrics Changes - The Engineering and Scientific segment represented 84% of revenues before reimbursement, with revenues flat in Q1 2025 [20] - The Environmental and Health segment represented 16% of revenues before reimbursement, with a 2% increase driven by engagements in the chemicals industry [21] Market Data and Key Metrics Changes - The consumer products industry accounts for approximately 25% of revenue, with two-thirds being proactive work for consumer electronics clients [8] - The energy industry represents about 20% of revenue, split evenly between reactive and proactive services [9] - The transportation industry contributes mid-teens percentage of revenue, with approximately 90% being reactive [10] Company Strategy and Development Direction - The company maintains a diversified business model, with 60% of work being reactive and 40% proactive, focusing on litigation support and regulatory consulting [7][34] - The company is strategically hiring in areas with increasing demand, such as automated vehicles and digital health [62] - The company anticipates long-term growth opportunities driven by technological advancements and increasing safety and health expectations [30] Management's Comments on Operating Environment and Future Outlook - Management noted macroeconomic uncertainties but expressed confidence in the company's resilience through economic cycles [13] - The company expects revenue before reimbursements to grow in the low single digits for fiscal 2025, maintaining margin guidance [21] - Management highlighted ongoing opportunities in regulatory consulting and compliance work, particularly in the chemicals industry [28] Other Important Information - The company experienced a negative tax impact associated with share-based awards, resulting in a consolidated tax rate of 29.4% for Q1 2025 [16] - Capital expenditures for the full year 2025 are expected to be between $10 million and $12 million [27] Q&A Session Summary Question: Growth rates in proactive and reactive work - Reactive business grew in the low single digits, offset by a slight decline in proactive services overall [33] Question: Changes in productivity across end markets - Clients are exploring supply chain diversification, which may take time to manifest [36] Question: Second quarter outlook and utilization - Utilization is expected to be slightly below last year, impacted by the July 4 holiday and some delays in client projects [42][44] Question: Impact of government policies and macro environment - Clients are tightening budgets but continue to proceed with necessary work, indicating resilience in the business [56] Question: FTE growth in a choppy environment - The company plans to continue hiring in areas of increasing demand, expecting a 4% increase in headcount by year-end [63]

Revenue Performance - Total revenues for Q1 2025 were approximately flat at $145.5 million, compared to $144.9 million in Q1 2024[5] - Exponent anticipates low-single digit revenue growth for the full fiscal year 2025 compared to fiscal year 2024[10] - The engineering and other scientific segment accounted for 84% of revenues before reimbursements, remaining flat year-over-year[8] - The environmental and health segment represented 16% of revenues before reimbursements, with a 2% increase driven by the chemicals industry[9] Income and Profitability - Net income decreased to $26.7 million, or $0.52 per diluted share, down from $30.1 million, or $0.59 per diluted share in Q1 2024[6] - EBITDA decreased to $37.5 million, representing 27.3% of net revenues, compared to $40.1 million, or 29.2% of net revenues in Q1 2024[7] - Exponent's operating income for Q1 2025 was $44.4 million, compared to $30.7 million in Q1 2024[22] - Net income for the quarter ended April 4, 2025, was $26,650 million, a decrease of 4.9% from $30,142 million in the same quarter of 2024[28] - EBITDA for the quarter was $37,538 million, down 6.4% from $40,121 million year-over-year[28] - EBITDAS for the quarter was $45,717 million, a decline of 3.7% compared to $47,461 million in the previous year[28] Expenses and Taxation - Income taxes increased to $11,110 million from $10,281 million, reflecting a rise of 8.1%[28] - Stock-based compensation rose to $8,179 million, up 11.4% from $7,340 million in the prior year[28] - Depreciation and amortization expenses increased to $2,492 million, compared to $2,324 million, marking a growth of 7.2%[28] - Interest income, net, was $(2,714) million, slightly higher than $(2,626) million in the previous year[28] - The consolidated tax rate for Q1 2025 was 29.4%, up from 25.4% in Q1 2024[6] Cash and Dividends - The company plans to maintain its quarterly cash dividend of $0.30, with $16.4 million paid in dividends during Q1 2025[7] - Exponent closed the quarter with $245.1 million in cash and cash equivalents[7] Operating Performance Measures - The company emphasizes that EBITDA and EBITDAS are useful measures of operating performance and cash flow, providing meaningful comparisons of past, present, and future results[29] - Management believes that non-GAAP measures like EBITDA and EBITDAS should be considered in addition to GAAP measures for a comprehensive view of financial performance[29] - The company continues to focus on enhancing operating performance despite the decline in net income and EBITDA metrics[29]

Core Viewpoint - Exponent, Inc. has declared a quarterly cash dividend of $0.30 per share, reflecting its commitment to shareholder value amidst macroeconomic challenges [1][3]. Dividend Information - The quarterly cash dividend of $0.30 per share will be paid on June 20, 2025, to shareholders of record as of June 6, 2025 [1]. - Exponent plans to continue paying quarterly dividends each year in March, June, September, and December, subject to the Board's final determination [2]. Company Strategy and Positioning - The company emphasizes its diversified services portfolio, which positions it to withstand short-term volatility while pursuing long-term growth opportunities [3]. - Exponent integrates over 90 technical disciplines and employs more than 950 consultants to address complex challenges across various industries [3][4]. Global Operations - Exponent's consultants leverage multidisciplinary expertise and resources from offices in North America, Asia, and Europe, enabling the delivery of high-value insights to clients [4].

Core Insights - Exponent, Inc. reported first quarter results for fiscal year 2025, showing resilience in its diversified business model despite challenges in the consumer electronics sector [2][4][9] Financial Performance - Total revenues for Q1 2025 were approximately flat at $145.5 million compared to $144.9 million in Q1 2024, while revenues before reimbursements were $137.4 million, slightly up from $137.2 million [4] - Net income decreased to $26.7 million, or $0.52 per diluted share, down from $30.1 million, or $0.59 per diluted share in the same period last year [5][22] - EBITDA fell to $37.5 million, representing 27.3% of net revenues, compared to $40.1 million, or 29.2% of net revenues in Q1 2024 [6][27] Business Segments - The engineering and other scientific segment accounted for 84% of revenues before reimbursements, remaining flat year-over-year, driven by demand in transportation and utilities [7] - The environmental and health segment represented 16% of revenues before reimbursements, with a 2% increase attributed to higher engagements in the chemicals industry [8] Business Outlook - Exponent anticipates low-single-digit revenue growth for the full fiscal year 2025, maintaining its guidance despite facing headwinds in the second quarter [9][17] - The company is returning to a 52-week fiscal year in 2025, which may impact full-year comparisons due to the previous year's 53-week benefit [10]

Core Insights - Exponent, Inc. will report its First Quarter of fiscal year 2025 financial results on May 1, 2025, after market close [1] - The conference call to discuss the financial results will be hosted by Dr. Catherine Corrigan and Richard Schlenker at 4:30 p.m. ET [1][2] - A live and archived webcast of the conference call will be available on the company's Investor Relations website [2] Company Overview - Exponent integrates over 90 technical disciplines with more than 950 consultants to assist clients in navigating complex industry challenges [3] - The company focuses on failure analysis and developing solutions aimed at creating a safer, healthier, and more sustainable world [3] - Exponent's consultants leverage multidisciplinary expertise and resources globally, providing insights to various sectors including multinational companies, startups, law firms, and governments [4]